These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 10574596)

  • 1. Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas.
    Rao UN; Finkelstein SD; Jones MW
    Mod Pathol; 1999 Nov; 12(11):1001-9. PubMed ID: 10574596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 immunoreactivity and mutation of the p53 gene in smooth muscle tumours of the uterine corpus.
    Jeffers MD; Farquharson MA; Richmond JA; McNicol AM
    J Pathol; 1995 Sep; 177(1):65-70. PubMed ID: 7472782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 alterations in uterine leiomyosarcomas versus leiomyomas.
    de Vos S; Wilczynski SP; Fleischhacker M; Koeffler P
    Gynecol Oncol; 1994 Aug; 54(2):205-8. PubMed ID: 8063247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins.
    Amada S; Nakano H; Tsuneyoshi M
    Int J Gynecol Pathol; 1995 Apr; 14(2):134-42. PubMed ID: 8601525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen and progesterone receptor expression in patients with uterine smooth muscle tumors.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    Fertil Steril; 2004 Apr; 81(4):1062-6. PubMed ID: 15066464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Ki-67, P53 and progesterone receptors in uterine smooth muscle tumors. Diagnostic value.
    Petrović D; Babić D; Forko JI; Martinac I
    Coll Antropol; 2010 Mar; 34(1):93-7. PubMed ID: 20437637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent occurrence of loss of heterozygosity among tumor suppressor genes in uterine leiomyosarcoma.
    Zhai YL; Nikaido T; Orii A; Horiuchi A; Toki T; Fujii S
    Gynecol Oncol; 1999 Dec; 75(3):453-9. PubMed ID: 10600306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cluster analysis of immunohistochemical markers in leiomyosarcoma delineates specific anatomic and gender subgroups.
    Carvalho JC; Thomas DG; Lucas DR
    Cancer; 2009 Sep; 115(18):4186-95. PubMed ID: 19626649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS).
    Mayerhofer K; Lozanov P; Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K
    Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1085-8. PubMed ID: 15488127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the c-myc proto-oncogene occurs frequently in uterine sarcomas.
    Jeffers MD; Richmond JA; Macaulay EM
    Mod Pathol; 1995 Sep; 8(7):701-4. PubMed ID: 8539225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors.
    Mittal K; Demopoulos RI
    Hum Pathol; 2001 Sep; 32(9):984-7. PubMed ID: 11567229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma.
    Leiser AL; Anderson SE; Nonaka D; Chuai S; Olshen AB; Chi DS; Soslow RA
    Gynecol Oncol; 2006 Apr; 101(1):86-91. PubMed ID: 16289259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
    Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
    Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis.
    Bodner-Adler B; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
    Gynecol Oncol; 2005 Jan; 96(1):62-6. PubMed ID: 15589581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma.
    Leitao MM; Soslow RA; Nonaka D; Olshen AB; Aghajanian C; Sabbatini P; Dupont J; Hensley M; Sonoda Y; Barakat RR; Anderson S
    Cancer; 2004 Sep; 101(6):1455-62. PubMed ID: 15316901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival.
    Younes M; Juarez D; Lechago LV; Lerner SP
    Anticancer Res; 2001; 21(1B):575-8. PubMed ID: 11299807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Immunoreactivity of p16 in leiomyosarcomas and leiomyoma variants.
    Gannon BR; Manduch M; Childs TJ
    Int J Gynecol Pathol; 2008 Jan; 27(1):68-73. PubMed ID: 18156978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of the ERα/ERβ ratio and neurotensin and its high-affinity receptor in myometrium, uterine leiomyoma, atypical leiomyoma, and leiomyosarcoma.
    Rodríguez Y; Báez D; de Oca FM; García C; Dorta I; Reyes R; Valladares F; Almeida TA; Bello AR
    Int J Gynecol Pathol; 2011 Jul; 30(4):354-63. PubMed ID: 21623207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
    Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
    Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.